Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
8
Number of overlapping holdings
28.6%
% of PBE's 28 holdings also in IDNA
17.8%
% of IDNA's 49 holdings also in PBE
Overlap by Weight
Sector Drift (PBE minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBE |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 5.1% | 5.9% | 5.1% |
|
INCYTE CORP | 4.7% | 4.9% | 4.7% |
|
REGENERON PHARMACEUTICALS | 4.9% | 3.1% | 3.1% |
|
SAREPTA THERAPEUTICS INC | 3.0% | 4.2% | 3.0% |
|
EXELIXIS INC | 2.7% | 6.7% | 2.7% |
Position Highlights (Non-Overlapping Exposures)
PBE Overweight Relative to IDNA
|
NATERA INC | 5.1% |
|
ILLUMINA INC | 5.1% |
|
UNITED THERAPEUTICS CORP | 5.0% |
|
BIOGEN IDEC INC | 4.8% |
|
AMGEN INC | 4.7% |
|
EXACT SCIENCES CORP | 3.1% |
|
VERACYTE INC | 2.9% |
|
ACADIA PHARMACEUTICALS INC | 2.9% |
|
BIO-TECHNE CORPORATION | 2.8% |
|
BIOMARIN PHARMACEUTICAL INC | 2.8% |
PBE Underweight Relative to IDNA
 |
BIONTECH SE SPONSORED ADR | -5.0% |
 |
BEIGENE, LTD. | -4.8% |
|
REVOLUTION MEDICINES, INC. | -4.7% |
 |
ROCHE HOLDING LTD | -4.4% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -4.2% |
|
EXELIXIS INC | -4.1% |
 |
SANOFI-AVENTIS | -4.0% |
|
ARCELLX, INC. | -3.9% |
 |
GSK PLC | -3.4% |
|
MERCK & CO. INC. | -3.3% |